Where opportunities exist for QIAGEN in the protein isolation marketplace?
Mr. Schatz: The brand equity of QIAGEN is clearly associated with sample preparation and with our focus on nucleic acids but we also have a very strong position and a focus on protein expression and purification. We are the leading player in recombinant protein purification and expression systems with a strong IP position in this area. So we are in many cases the leader in this space as well. Right now it is less visible, but a lot of people in the research community will clearly identify this as a key technology for their research. With an increasing activity in functional genomics, research is going more and more into a system biology approach. People start looking at nucleic acid and proteins in parallel to analyze the interaction of the different gene functions in a cell. We have a suite of protein purification products and we have integrated solutions as well. We at QIAGEN believe that genomics fuels proteomics, and in turn proteomics fuels genomics. Nucleic acids have the beauty
